Oncolys BioPharma
Manufacturing · Japan · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Toranomon Towers Office 4-1-28 toranomon...Phone Number
(201) 527-0953Website
www.oncolys.comRevenue
<$5 MillionIndustry
About Oncolys BioPharma
Oncolys BioPharma Org Chart
Is Oncolys BioPharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Oncolys BioPharma recently announced quarterly report
Oncolys BioPharma, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Oncolys BioPharma launches new products
Check if Oncolys BioPharma has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Oncolys BioPharma has new funding data
Congratulate Masked Content for being promoted to Masked Content at Oncolys BioPharma
Click to see if Oncolys BioPharma had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Oncolys BioPharma is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
Oncolys BioPharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Oncolys BioPharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Oncolys BioPharma.
Oncolys BioPharma Tech Stack
A closer look at the technologies used by Oncolys BioPharma
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Oncolys BioPharma
Oncolys BioPharma Inc. is a biopharmaceutical company focused on developing innovative therapies for cancer treatment. Their product pipeline includes various drug candidates such as Telomelysin (OBP-301) and OBP-702, aimed at addressing unmet medical needs in oncology. The company targets healthcare providers and institutions involved in cancer ca... Read More